FDA Approved: DUTASTERIDE — Supplemental Application (XLCare Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for dutasteride filed by XLCare Pharmaceuticals, Inc., resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia
• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)

Snippet

SUPPL AP for DUTASTERIDE (DUTASTERIDE)